9
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Naturally Occurring Anti-Idiotypic Antibodies to Anti-Phosphotyrosine in Systemic Lupus Erythematosus Interact with SRC-Homology 2 Domains

, , , , &
Pages 81-86 | Received 04 Oct 1995, Published online: 07 Jul 2009

References

  • Stefanescu M., Cremer L., Matache C., Cristescu C., Szegli G. Anti-phosphotyrosine and anti-phosphoserine antibodies in SLE sera. Roum. Arch. Microbiol. Immunol. 1991; 3: 193–197
  • Stefanescu M., Matache C., Onu A., Cristescu G., Cremer L., Szegli G. Identification of anti-idiotypic antibodies to anti-phosphotyrosine antibodies in human sera. Autoimmunity 1993; 15: 181–186
  • Songyang Z., Shoelson S. E., Chaudhuri M., Gish G., Pawson T., Haser W. G., King R., Roberts T., Ratnofsky S., Lechleider R. J., Neel B. G., Birge R. B., Fajardo J. E., Chou M. M., Hanafusa H., Schaffhausen B., Cantley L. C. SH2 Domains Recognize Specific Phosphopeptide Sequences. Cell 1993; 72: 767–778
  • Waksman G., Shoelson S. E., Pant N., Cowburn D., Kuriyan J. Binding of a High Affinity Phosphotyrosyl Peptide to the Sre SH2 Domain: Crystal Structures of the Complexed and Peptide-free Forms. Cell 1993; 72: 779–790
  • Bougeret C., Rothhut B., Julien P., Fischer S., Benarous R. Recombinant Csk expressed in Escherichia coli is autophosphorylated on tyrosine residue(s). Oncogene 1993; 8: 1241–1247
  • Sabe H., Hata A., Okada M., Nakagawa H., Hanafusa H. Analysis of the binding of the Sre homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Sre. Proc. Natl. Acad. Sci. USA 1994; 91: 3984–3988

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.